- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We're Reading: Despite California Law, Women Struggle to Access Birth Control
What we're reading, November 1, 2016: despite law, women in California still struggle to access birth control; Americans mostly believe obesity can be fixed through willpower; and Facebook is going after pharmaceutical advertisements.
A California law has made it possible for women to get birth control at the pharmacy without a doctor’s prescription. However, women still have trouble finding pharmacists implementing the law and prescribing birth control, according to the Los Angeles Times. Although the law was passed in 2013, it didn’t go into effect until April 2016, and since pharmacists aren’t required to provide birth control, they may never choose to. California is 1 of 3 states that passed such a law.
Despite evidence that obesity is a genetic condition, a majority of Americans still blame the health threat on willpower. According to the New York Times, a survey of 1509 adults found three-fourths of respondents said the best treatment for obesity was diet and exercise. However, research has proven that obesity is the result of the environment and genetics. In fact, 94% of survey participants who were obese said diet and exercise was not successful no matter how many times they tried.
More drug ads might soon be on Facebook as the social media giant opens the door for Big Pharma’s advertising. Drug makers will also be able to block comments on pages promoting a specific product and sponsor community pages that bring together people with the same medical condition, reported STAT. Social media can be a difficult space for pharmaceutical companies, which have to follow regulations, such as including side effects on drug ads. Bayer had the first ad, only appearing on mobile, promoting an auto-injector for a multiple sclerosis medication.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
